scholarly journals Understanding Differences in Cancer Survival between Populations: A New Approach and Application to Breast Cancer Survival Differentials between Danish Regions

Author(s):  
Marie-Pier Bergeron-Boucher ◽  
Jim Oeppen ◽  
Niels Vilstrup Holm ◽  
Hanne Melgaard Nielsen ◽  
Rune Lindahl-Jacobsen ◽  
...  

Large variations in cancer survival have been recorded between populations, e.g., between countries or between regions in a country. To understand the determinants of cancer survival differentials between populations, researchers have often applied regression analysis. We here propose the use of a non-parametric decomposition method to quantify the exact contribution of specific components to the absolute difference in cancer survival between two populations. Survival differences are here decomposed into the contributions of differences in stage at diagnosis, population age structure, and stage-and-age-specific survival. We demonstrate the method with the example of differences in one-year and five-year breast cancer survival between Denmark’s five regions. Differences in stage at diagnosis explained 45% and 27%, respectively, of the one- and five-year survival differences between Zealand and Central Denmark for patients diagnosed between 2008 and 2010. We find that the introduced decomposition method provides a powerful complementary analysis and has several advantages compared with regression models: No structural or distributional assumptions are required; aggregated data can be used; and the use of absolute differences allows quantification of the survival that could be gained by improving, for example, stage at diagnosis relative to a reference population, thus feeding directly into health policy evaluation.

2019 ◽  
Vol 146 (5) ◽  
pp. 1208-1218 ◽  
Author(s):  
Walburga Y. Joko‐Fru ◽  
Adalberto Miranda‐Filho ◽  
Isabelle Soerjomataram ◽  
Marcel Egue ◽  
Marie‐Therese Akele‐Akpo ◽  
...  

2011 ◽  
Vol 20 (10) ◽  
pp. 2160-2167 ◽  
Author(s):  
Amanda J. Sheppard ◽  
Anna M. Chiarelli ◽  
Loraine D. Marrett ◽  
E. Diane Nishri ◽  
Maureen E. Trudeau

2015 ◽  
Vol 112 (S1) ◽  
pp. S124-S128 ◽  
Author(s):  
M J Rutherford ◽  
G A Abel ◽  
D C Greenberg ◽  
P C Lambert ◽  
G Lyratzopoulos

Thorax ◽  
2021 ◽  
pp. thoraxjnl-2020-216555
Author(s):  
Marzieh Araghi ◽  
Miranda Fidler-Benaoudia ◽  
Melina Arnold ◽  
Mark Rutherford ◽  
Aude Bardot ◽  
...  

IntroductionLung cancer has a poor prognosis that varies internationally when assessed by the two major histological subgroups (non-small cell (NSCLC) and small cell (SCLC)).Method236 114 NSCLC and 43 167 SCLC cases diagnosed during 2010–2014 in Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK were included in the analyses. One-year and 3-year age-standardised net survival (NS) was estimated by sex, histological type, stage and country.ResultsOne-year and 3-year NS was consistently higher for Canada and Norway, and lower for the UK, New Zealand and Ireland, irrespective of stage at diagnosis. Three-year NS for NSCLC ranged from 19.7% for the UK to 27.1% for Canada for men and was consistently higher for women (25.3% in the UK; 35.0% in Canada) partly because men were diagnosed at more advanced stages. International differences in survival for NSCLC were largest for regional stage and smallest at the advanced stage. For SCLC, 3-year NS also showed a clear female advantage with the highest being for Canada (13.8% for women; 9.1% for men) and Norway (12.8% for women; 9.7% for men).ConclusionDistribution of stage at diagnosis among lung cancer cases differed by sex, histological subtype and country, which may partly explain observed survival differences. Yet, survival differences were also observed within stages, suggesting that quality of treatment, healthcare system factors and prevalence of comorbid conditions may also influence survival. Other possible explanations include differences in data collection practice, as well as differences in histological verification, staging and coding across jurisdictions.


2003 ◽  
Vol 106 (3) ◽  
pp. 416-422 ◽  
Author(s):  
Milena Sant ◽  
Claudia Allemani ◽  
Riccardo Capocaccia ◽  
Timo Hakulinen ◽  
Tiiu Aareleid ◽  
...  

2014 ◽  
Vol 27 (3) ◽  
pp. 325 ◽  
Author(s):  
Maria do Rosario André ◽  
Sandra Amaral ◽  
Alexandra Mayer ◽  
Ana Miranda ◽  
Working Group ROR SUL

<p><span lang="EN-GB"><strong>Objectives:</strong> Although the breast cancer incidence in Portugal is lower than the European average, it is the most frequent cancer in women. Overall, mortality rates are heterogeneous throughout Portugal. Implicated factors may include demographic and socioeconomic aspects, tumor biological characteristics, and access to medical care. The aim of this study is to detect survival differences in female breast cancer and identify the main associated factors.<br /><strong>Material and Methods:</strong> We have conducted a population-based, retrospective cohort study with follow-up. Incident breast cancer cases diagnosed in 2005 of residents in the southern region of Portugal were included. Data was collected from the Southern Portugal Cancer Registry (ROR-Sul) database and completed with clinical chart information.<br /><strong>Results:</strong> A total of 1 354 patients were included in this study. Observed geographical variations were as follows: for age distribution, with an aging population in Alentejo; for tumor sub-types, there was a higher incidence of HER2-positive tumors in the Algarve and a higher incidence of HER2-negative tumors in Região Autónoma da Madeira. Reported estimated 5-year overall survival was 80%, with significant association with tumor stage, hormone receptor and HER2 status. No survival differences were identified among women from distinct geographical regions.<br /><strong>Discussion:</strong> Although we found differences in age and tumor sub-type distribution between geographical regions, our study does not support the existence of discrepancies in breast cancer survival between these regions. Tumor biological characteristics seem to be the main associated factor with breast cancer survival in our population.<br /><strong>Conclusions:</strong> Our study confirms the association between patient survival and tumor stage, hormone receptor and HER2 status. However, no differences in patient survival were observed among different regions of residence.<br /><strong>Keywords:</strong> Breast Neoplasms; Neoplasm Staging; Survival Analysis; Portugal.</span></p>


2003 ◽  
Vol 107 (6) ◽  
pp. 1058-1058
Author(s):  
M Sant ◽  
C Allemani ◽  
R Capocaccia ◽  
T Hakulinen ◽  
T Aareleid ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document